Metraipolis › archive › dc_277bfac04a22
Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans — Europe PMC PMID:39485782
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39485782
- DOI
- 10.1371/journal.pone.0307746
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T15:12:53.143Z
- SHA-256 of the archived text
e5eb089decd35618b8504c9a8e65fe57743ced39970eeeaeeee8de37d05be38c- Stable URL of this page
https://metraipolis.com/documento/dc_277bfac04a22
How to cite
Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans — Europe PMC PMID:39485782 — Europe PMC (en), https://europepmc.org/article/MED/39485782 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_277bfac04a22 (Metraipolis archive dc_277bfac04a22, sha256 e5eb089decd35618b8504c9a8e65fe57743ced39970eeeaeeee8de37d05be38c)
BibTeX
@misc{dc277bfac04a22,
title = {Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans — Europe PMC PMID:39485782},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39485782},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_277bfac04a22; sha256 e5eb089decd35618b8504c9a8e65fe57743ced39970eeeaeeee8de37d05be38c},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39485782. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Incidence of hepatocellular carcinoma (HCC) had been increasing steadily among older Americans but plateaued in 2015-2017. Chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) are important causes of HCC. The impact of improved treatments for these infections on recent trends in HCC incidence is unclear. Aims: To examine the relationship between use of antiviral therapy for chronic viral hepatis and HCC incidence in older Americans. Methods: We used 2007-2017 data from the Surveillance, Epidemiology, and End Results-Medicare database to estimate age-standardized incidence rates and average annual percent changes (AAPCs) for viral hepatitis-attributable HCC among individuals ≥66 years. We analyzed data from Medicare Part D to determine the frequency of HBV and HCV treatment utilization in this population. Results: Overall HCC incidence increased 10.5%, from 22.2/100,000 in 2007 to 24.5/100,000 in 2017 (AAPC, 1.3%). During that time, HBV-attributable HCC rates decreased from 2.5 to 2.0/100,000 (AAPC, -1.6%), while HCV-attributable HCC rose from 6.6 to 8.0/100,000 (AAPC, 2.0%). HBV treatment among patients with HBV infection increased by 66% (2007, 7.4%; 2015, 12.3%). Treatment for HCV was stable at <2% during 2006-2013 but rose to 6.9% in 2014 and 12.7% in 2015, coinciding with the introduction of direct acting antiviral agents for HCV. Conclusions: A decreased incidence of HBV-attributable HCC corresponded with an increased uptake in treatment for that infection. Despite a marked increase in the effectiveness and frequency of HCV treatment in 2014 and 2015, HCV-attributable HCC had not begun to fall as of 2017. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-11-01). Identificativi: PMID 39485782 · PMCID PMC11530004 · DOI 10.1371/journal.pone.0307746. Descrittori MeSH principali: Carcinoma, Hepatocellular; Liver Neoplasms; Antiviral Agents; SEER Program. Pagina: https://europepmc.org/article/MED/39485782 — https://doi.org/10.1371/journal.pone.0307746. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T15:11:36.261Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.